Archer Materials Ltd. focuses on developing advanced semiconductor devices, including chips relevant to quantum computing and medical diagnostics. The firm is progressing the development of 12CQ quantum computing qubit processor chip (12CQ chip) and lab-on-a-chip biochip technology (biochip). Its 12CQ qubit processor chip technology catalyzes the global quantum computing industry by servicing existing and emerging consumer markets reliant on increased computational power, such as artificial intelligence (AI) and blockchain technologies like digital currencies. The company is developing the A1 Biochip, a lab-on-chip technology that incorporates graphene, the thinnest material known, to provide an ultrasensitive biochemical interface for multi-disease detection and compatibility with digitized processing for biosensor device integration.


Investor Insights Hub

Watch Archer Materials (ASX: AXE) CEO Dr Mohammad Choucair discuss developing innovative deep tech for commercialisation in the multi-billion-dollar global industries of quantum technology and human health. Recorded at the ASX Small and Mid-Cap Conference in September 2022.

Investors can stay up to date with the latest news, developments, events, and announcements from Archer by subscribing here.


Here are the latest articles on Archer Materials (ASX: AXE)

Archer Materials delivers breakthrough proof-of-concept devices for quantum computing chip production

Driving Australia forward in the global arms race towards quantum computing accessibility, Australian semiconductor company Archer Materials (ASX: AXE) has successfully produced two proof-of-concept (POC) electrical devices that enhance the manufacturability of their 12CQ quantum computing chip.  The two newly developed devices improve the detection and readout of quantum information from Archer’s proprietary spin material,

Archer begins new experiments for its lab-on-a-chip for kidney disease detection

According to the Australian Institute of Health and Welfare, there are more than 1.7 million Australians that live with the biomedical signs of chronic kidney disease. While not all will deteriorate to kidney failure, it leads to the 22,000 deaths annually which could be reduced from earlier detection and better management, an initiative launched by

Archer Materials advances Biochip technology with new design for manufacturing to be tested in Finland

Australian semiconductor company Archer Materials (ASX: AXE) has progressed its latest Biochip design to the next phase of development by dispatching it to the VTT Technical Research Centre of Finland Ltd (VTT) for manufacturing. The Biochip’s newest graphene field-effect transistor (gFET) design, which was announced in July 2024, marks a milestone in enhancing it’s functionality,

Archer unveils breakthrough testing method for graphene transistors to identify optimal stability and accuracy

Australian semiconductor company Archer Materials (ASX: AXE) has developed a novel graphene transistor test that will produce the most stable and accurate gFETs for future development activities and commercialisation of their biochip for the medical diagnostics industry.  The new procedure, designed to scrutinise the gFET sensors under various conditions and electrical operation modes, was developed

Archer achieves milestone in 12CQ quantum computing to improve its manufacturability

At a time when the Australian Government is putting a priority on investing in quantum computing and homegrown innovation, semiconductor company Archer Materials (ASX: AXE) has achieved a breakthrough in their 12CQ quantum project that will enhance its devices and progress toward practical quantum computing applications. Archer’s quantum project is led by newly appointed Chief

Archer Materials gains global exposure at the World Economic Forum tech conference

Archer Materials (ASX: AXE), recognised as a global leader in emerging technologies, recently showcased its innovations at the World Economic Forum (WEF) conference in San Francisco. CEO Dr. Mohammad Choucair (pictured) presented on advanced manufacturing value chains, discussing the semiconductor industry, the future of quantum computing and AI, at the event attended by over 230

International graphene foundry validates Archer’s Biochip towards commercial fabrication

Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the commercialisation of their graphene-based Biochip, a recent design of which has been successfully manufactured by foundry partner Graphenea in Spain, carving a pathway towards its future production. The milestone advances Archer’s Biochip capabilities in access to commercial semiconductor production facilities for technologies

Archer and the World Economic Forum flag groundbreaking strategies for rewiring global value chains

According to the World Economic Forum (WEF), the manufacturing industry will need to undertake a major structural shift in the face of emerging technology, climate change and geopolitical tensions that will be driven by economies of skill where global collaborations will be critical to fortifying value chains amidst ongoing disruptions.  The WEF White Paper, From

Archer develops precision sensing technology for 12CQ chip

Semiconductor company Archer Materials (ASX: AXE) has made notable technology development progress with its 12CQ quantum chip and its Biochip lab-on-a-chip technology. To progress the 12CQ chip development, Archer designed, developed and built a new type of device called a pulsed electron spin resonance (p-ESR) chip. Archer was able to leverage the expertise of Swiss-based

Archer Materials teams up with EPFL to build precision microsensors

Australian semiconductor company Archer Materials (ASX: AXE) has joined forces with Switzerland’s research institute École Polytechnique Fédérale de Lausanne (EPFL) to build a microchip aimed at revolutionising the study of quantum materials. The chip’s features open potential opportunities for Archer to develop quantum sensors, miniaturised spectrometers, and analytical devices for precision sensing. This new chip,

Archer Materials primed to deliver on chip tech milestones and manufacturing runs

If you’re somewhat versed in the tech world, you have probably heard terms like semiconductors, quantum computing and bioelectronics, and their potential to change the world. While some companies might suggest that these have a long way to go before they are usable by the layman, Archer Materials is readying to inject them into our

Archer Materials expands Biochip development with a semiconductor foundry in Spain

Working closer towards commercialising its cutting-edge graphene Biochip, semiconductor company Archer Materials (ASX: AXE) has dispatched its latest chip design iteration to a certified foundry in Spain for fabrication through a whole wafer manufacturing run. This move is part of Archer’s ongoing commitment to pushing the boundaries in both quantum computing and medical diagnostics while

From design to development: Archer successfully validates its Biochip gFET design with German foundry

According to UBS, 3.16 billion people cannot reach a healthcare facility by foot within an hour, with many battling with poverty and inaccessibility to resources. But what if people didn’t have to delay? What if they could use a microchip to diagnose, monitor and upload their data, which a doctor could digitally survey? That’s the

Archer makes major advances towards lab-on-a-chip technology

A semiconductor company with a quantum computing and medical diagnostics focus, Archer Materials Limited (ASX: AXE), has announced a notable development in its advanced Biochip graphene field effect transistor (gFET) technology. Archer has successfully demonstrated multiplexing readout capabilities for its Biochip, i.e. they have shown the device can make sense of multiple liquid samples arriving

Semiconductor foundry in Europe validates Archer’s graphene biochip design for advanced sensing

Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the next generation of medical diagnostics through the successful manufacture of its graphene ‘lab-on-a-chip’ biochip in a commercial semiconductor foundry. Scaling the design and production of graphene chips to be used as biological sensors is a significant challenge to commercialising what could potentially

Semiconductor chips: The ASX companies helming the next frontier of innovation

Imagine a world where the conveniences of smartphones, microwaves, social media platforms like Facebook and Instagram, online booking systems, precise navigation with Google Maps, contactless payments, and seamless phone calls cease to exist. If this scenario seems unsettling, you’re not alone. Our lives are intricately intertwined with the digital realm, and this interconnectedness hinges on

As NVIDIA revenue sees 101% boost, investors see massive opportunity for ASX semiconductor tech stocks

Sitting snug among companies with the largest market caps, from Apple to Amazon, Alphabet and more, US-based AI computing company Nvidia (NASDAQ: NVDA) makes a strong case for the growth of semiconductor companies worldwide. In 2022, global semiconductor sales reached US$963 billion, marking an increase of over 30% in just two years. And it is

Archer’s biochip edges closer to commercialisation with recent advances towards multiplexing

Semiconductor company Archer Materials (ASX: AXE) has just hit a new milestone: an upgrade for its gFET (graphene field effect transistor) biochip design, aimed to enhance disease detection and control. This comes just a few weeks after it engaged with commercial foundry partners in Germany to begin a multi-project wafer run (an ‘MPW’) of the

Archer quietly shattering coherence records for quantum computing with big cash runway

In the rapidly advancing field of quantum computing, Archer Materials (ASX: AXE) has managed to make groundbreaking progress. The Australian semiconductor company has been pushing the boundaries of quantum coherence times and making significant strides towards commercialising their qubit processor technology without the hype or overspending. Quantum coherence time, a critical metric in quantum computing,

Archer commences foundry discussions for production of graphene biochip

Australian semiconductor company Archer Materials (ASX: AXE) has taken a major step forward towards the commercialisation of its biosensing graphene transistor technology with the transfer of its chip designs to a commercial foundry to initiate a production run. The company’s partnerships with international semiconductor fabs have advanced this year, with Archer having completed its optical

Archer makes breakthrough in development of 12CQ chip by preserving quantum functionality at room temperature in air

Quantum computing has emerged as a cutting-edge field with the potential to revolutionise various aspects of technology, from cryptography and optimisation to drug discovery and artificial intelligence. One critical factor that plays a pivotal role in the performance of quantum computers is the conditions in which their qubit processors are required to operate. They include

Archer boosts its qubit material performance at room temperature

Australian semiconductor company Archer Materials (ASX: AXE) has reached a significant milestone in engineering its cutting-edge qubit material, which will likely play a role in future generations of powerful quantum computing. A qubit is the fundamental unit of information in quantum computing. Archer is one of few companies in the world developing qubit processors, chips,

Rising demand for AI capabilities send NVIDIA into $1Tn club, here’s the ASX semiconductor companies to watch

Last week, the NASDAQ reached its highest level since August 2022 thanks to immense growth in Artificial Intelligence (AI) and associated NASDAQ-listed companies. The combined market value of tech companies listed on the NASDAQ Composite index stood at US $22 trillion, up from US$18 trillion at the end of 2022 with the AI-driven rally contributing

Archer becomes first Australian company to partner with the World Economic Forum’s Centre for Fourth Industrial Revolution

The first industrial revolution saw the rise of factories and mass production, the second brought about cars and phones, the third brought about the internet and globalisation, and the fourth—the one we’re currently living through—is advancing artificial intelligence, automation and more. Each new industrial revolution has brought about a transformation that we can’t imagine our

Archer ticks off quantum milestones with zero debt and the backing of world’s largest semiconductor foundry

In a trillion-dollar industry so inundated by competitors, Aussie semiconductor company Archer Materials (ASX: AXE) has managed to stand out and make a name for itself with its unique qubit processor technology, the 12CQ chip, which is paving the path for mobile quantum computing devices. It has the backing of the largest semiconductor chip producer,

Archer gains access to the largest chipmaker TSMC’s development technology, to speed up its quantum chip ambitions

Taiwan-based semiconductor foundry—the largest chip developer in the world—TSMC, has accepted Australian semiconductor company Archer Materials (ASX: AXE) as their customer. This exciting development means that Archer will be able to access some of the most advanced semiconductor fabrication process in the world to help service and support the build out of its quantum technologies.

Archer marches towards broad use with biochip advancement

*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

Australian semiconductor company Archer joins major innovation collaboration program to expand globally

ASX-listed semiconductor company Archer Materials (ASX: AXE) has increased its global presence as an industry leader, joining the Academia-Industry Collaboration Program, with a team to be based in Switzerland.

Supercomputers validate Archer’s qubit processor in major step forward for quantum computing

Quantum computing is an area of technology that you can expect to hear a lot more of in the next 10 years. The whole industry is immensely complicated, but major developments are accelerating, at least in the case of the only ASX-listed quantum semiconductor company Archer Materials (ASX: AXE). For the first time, Archer has

Archer delivers biochip milestone with a system integrating robots and wettable electronics

Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the commercialisation of their deep tech biochip that could soon be used to detect some of the world’s most deadly transmittable diseases thanks to a major tech milestone. The milestone has been achieved in an early-stage prototype where Archer successfully implemented an integrated

Archer Materials chipping away at quantum computing

One of Australia’s most watched chip developers, Archer Materials (ASX: AXE), has joined forces with semiconductor manufacturer GlobalFoundries to advance its quantum chip technology. The two companies will be working in partnership to develop Archers’ ¹²CQ quantum chip technology and scale up manufacturing. Archer will be utilising GlobalFoundries’ facilities and production processes to explore the

More patents! Archer Materials adds Hong Kong to the list

Almost a year since their US patent was granted, Archer Materials (ASX: AXE) has added yet another patent to their portfolio, this time, in Hong Kong.  The new patent represents another major milestone, protecting Archer’s IP in the world’s second largest economy.  Already granted a patent in China, the Hong Kong patent validates Archer’s tech

Quantum chips, biochips, hot chips, poker chips… Archer responds to media misgivings

In a fumble of the facts, a popular Australian business masthead has been called out by one of the ASX’s hottest stocks over the past 12 months for factual errors in a piece yesterday titled “Archer Materials didn’t disclose Australian patent body’s objections”. The article made some market altering statements, publishing that Archer’s (ASX: AXE)

Archer secures access to $150m deep tech facility to advance nano-biochip for disease detection

Continued emergence of graphene and its application in biotech is being led by homegrown tech company Archer Materials (ASX: AXE) which has secured access to a $150 million world-class research facility to advance their biochip development. The facility provides Archer with instruments to test its semiconductor device production processes. Key to the deep tech access

Archer links up with leading AI firm to test real-world quantum computing applications

Advanced materials and deep tech company Archer Materials (ASX: AXE) is inching closer towards commercialsation of their world-first quantum computing chip through a new collaboration with artificial intelligence firm Max Kelsen. The collaboration comes with both companies being members of the IBM Q Network, which Archer was admitted to earlier in the year, and will

Archer partners with IBM to advance quantum computing, shares surge 105%

Australian tech company Archer Materials (ASX: AXE) has secured one of the most high-profile of partners in IBM (NYSE: IBM) to advance the development of its world-first quantum computing processor chip that can operate at room temperature.  The partnership is a game changer for Archer, which will see its Sydney-based team collaborate with the IBM

Testing confirms Archer’s high-value graphite for Li-ion batteries

Despite graphite being listed as a ‘critical mineral’ by global leaders, it is not currently produced in Australia. However, that could soon change with Archer Materials (ASX: AXE) confirming testing from its Campoona Prospect to be of the high quality required to produce coated spherical graphite for use in lithium-ion batteries.  The testing was conducted

Recent Articles